Sakashita, Takuya http://orcid.org/0000-0001-5778-7113
Nakamura, Yasuyuki
Sutoh, Yoichi
Shimizu, Atsushi
Hachiya, Tsuyoshi
Otsuka-Yamasaki, Yayoi
Takashima, Naoyuki
Kadota, Aya
Miura, Katsuyuki
Kita, Yoshikuni
Ikezaki, Hiroaki
Otonari, Jun
Tanaka, Keitaro
Shimanoe, Chisato
Koyama, Teruhide
Watanabe, Isao
Suzuki, Sadao
Nakagawa-Senda, Hiroko
Hishida, Asahi
Tamura, Takashi
Kato, Yasufumi
Okada, Rieko
Kuriki, Kiyonori
Katsuura-Kamano, Sakurako
Watanabe, Takeshi
Tanoue, Shiroh
Koriyama, Chihaya
Oze, Isao
Koyanagi, Yuriko N.
Nakamura, Yohko
Kusakabe, Miho
Nakatochi, Masahiro
Momozawa, Yukihide
Wakai, Kenji
Matsuo, Keitaro
Funding for this research was provided by:
KAKENHI (17015018, 221S0001, 17390186, 20390184, 24390165, 16H06277, 19H03902)
Article History
Received: 5 September 2022
Accepted: 15 January 2023
First Online: 27 January 2023
Declarations
:
: Takuya Sakashita is an employee of Takara Bio, Inc., Japan. Dr. Hachiya is a board member of Genome Analytics Japan Inc. Dr. Nakatochi reports receiving grants from Boehringer Ingelheim outside the submitted work. All other authors declare that they have no conflicts of interest associated with this study.
: All procedures were in accordance with the technical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. Informed consent was obtained from all participants before inclusion into the J-MICC study. The main study protocol of the J-MICC study was approved on July 20, 2005 by the Ethics Committee at Nagoya University School of Medicine (approval number 253).